Literature DB >> 11252322

The suppository form of antibiotic administration: pharmacokinetics and clinical application.

E Bergogne-Bérézin1, A Bryskier.   

Abstract

The rectal route of antibiotic administration might be used effectively when other routes of administration are inadequate or unsuitable. With the use of various adjuvants, the rectal route can provide satisfactory pharmacokinetics and acceptable local tolerance. Experiments in animals have demonstrated the influence of the pharmaceutical formulation of suppositories on the rectal absorption and systemic distribution of beta-lactams and aminoglycosides. In healthy volunteers and in children under treatment, similar adjuvants--mainly glyceride mixtures or non-ionic surface agents--have increased the rectal absorption of aminopenicillins, cephalosporins and macrolides. Other antibiotics, including metronidazole and cotrimoxazole, have been investigated in respect of their potential rectal administration.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11252322     DOI: 10.1093/jac/43.2.177

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  5 in total

1.  Implications on emergence of antimicrobial resistance as a critical aspect in the design of oral sustained release delivery systems of antimicrobials.

Authors:  Amnon Hoffman; Ehud Horwitz; Shmuel Hess; Ronit Cohen-Poradosu; Lilach Kleinberg; Anna Edelberg; Mervyn Shapiro
Journal:  Pharm Res       Date:  2007-10-16       Impact factor: 4.200

2.  Superiority of pulmonary administration of mepenzolate bromide over other routes as treatment for chronic obstructive pulmonary disease.

Authors:  Ken-Ichiro Tanaka; Shota Kurotsu; Teita Asano; Naoki Yamakawa; Daisuke Kobayashi; Yasunobu Yamashita; Hiroshi Yamazaki; Tomoaki Ishihara; Hiroshi Watanabe; Toru Maruyama; Hidekazu Suzuki; Tohru Mizushima
Journal:  Sci Rep       Date:  2014-03-28       Impact factor: 4.379

3.  Screening paediatric rectal forms of azithromycin as an alternative to oral or injectable treatment.

Authors:  Tina Kauss; Karen Gaudin; Alexandra Gaubert; Boubakar Ba; Serena Tagliaferri; Fawaz Fawaz; Jean-Louis Fabre; Jean-Michel Boiron; Xavier Lafarge; Nicholas J White; Piero L Olliaro; Pascal Millet
Journal:  Int J Pharm       Date:  2012-07-30       Impact factor: 5.875

4.  Pharmaceutical development and optimization of azithromycin suppository for paediatric use.

Authors:  Tina Kauss; Alexandra Gaubert; Chantal Boyer; Boubakar B Ba; Muriel Manse; Stephane Massip; Jean-Michel Léger; Fawaz Fawaz; Martine Lembege; Jean-Michel Boiron; Xavier Lafarge; Niklas Lindegardh; Nicholas J White; Piero Olliaro; Pascal Millet; Karen Gaudin
Journal:  Int J Pharm       Date:  2012-12-03       Impact factor: 5.875

5.  Pharmaceutical studies on and clinical application of olanzapine suppositories prepared as a hospital preparation.

Authors:  Kazuaki Matsumoto; Satoru Kimura; Kenichi Takahashi; Yuta Yokoyama; Masayuki Miyazawa; Satoko Kushibiki; Morio Katamachi; Junko Kizu
Journal:  J Pharm Health Care Sci       Date:  2016-09-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.